STAAR Surgical | STAA - Cash And Equivalent


STAAR Surgical reported $176.16M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 7.51B 560M Sep/2025
Bausch Health Companies USD 1.31B 419M Sep/2025
Boston Scientific USD 1.28B 741M Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
Exact Sciences USD 789.04M 131.94M Sep/2025
Hologic USD 2.17B 208.5M Dec/2025
J&J USD 18.23B 10.35B Sep/2025
Merit Medical Systems USD 392.46M 50.64M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
STAAR Surgical USD 176.16M 9.02M Sep/2025